All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2675 | Anti-CBR3 (CBFYC-0892) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Dog, Primate | CBFYC-0892 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2676 | Anti-CBR3 (CBFYC-0893) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0893 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5928 | Anti-CBR3 (CBFYC-0892) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Dog, Primate | CBFYC-0892 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5929 | Anti-CBR3 (CBFYC-0893) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-0893 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0123 | Anti-CBR3 (AT3C5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | AT3C5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0124 | Anti-CBR3 (XHM144) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM144 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0125 | Anti-CBR3 (XHM145) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | XHM145 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2415 | Anti-CBR3 (AT3C5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | AT3C5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2416 | Anti-CBR3 (XHM144) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM144 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2417 | Anti-CBR3 (XHM145) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | XHM145 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION